Melinta Therapeutics Stock Price - MLNT

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
After Hours
Last Trade
Last $ 1.27 ▼ -0.73 (-36.50%)
Company Name Stock Ticker Symbol Market Type
Melinta Therapeutics Inc MLNT NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.01 0.5% 2.00 2.15 1.99 2.02 1.99 19:58:25
Bid Price Ask Price Spread Spread % News
1.24 1.37 0.13 9.49% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,829 441,983 $ 2.03 $ 899,419 516,439 0.644 - 8.60
Last Trade Time Type Quantity Stock Price Currency
19:57:07 formt 3,000 $ 1.27 USD

Melinta Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 27.50M 13.75M $ -157.19M -18.00 - 12.58M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Melinta Therapeutics News

Loading Messages....

Latest MLNT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MLNT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.973.241.932.26489,740-0.97-32.66%
1 Month3.865.621.933.52582,883-1.86-48.19%
3 Months2.625.621.933.34439,406-0.62-23.66%
6 Months3.478.601.625.441,516,016-1.47-42.36%
1 Year2.768.600.6444.371,183,365-0.76-27.54%
3 Years11.9018.200.6444.89745,528-9.90-83.19%
5 Years11.9018.200.6444.89745,528-9.90-83.19%

Melinta Therapeutics Description

Melinta Therapeutics Inc is a clinical-stage biotechnology company that develops differentiated antibiotics for acute care and community settings. The company's goal is to develop treatments for bacterial infectious diseases, particularly respiratory tract infections and staphylococcal infections. The company is particularly focused on treating community-acquired bacterial pneumonia, as well as gonorrhea and other indications.


Your Recent History
NASDAQ
MLNT
Melinta Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.